Timothy Hultzman

Senior Associate


Tim Hultzman is a senior associate who focuses his practice on corporate and transactional work, including mergers and acquisitions, forming and advising early stage companies, and capital markets transactions. Some of his recent transactions include:

  • the sale of Prometric, a leading educational services company, by Educational Testing Service to Baring Private Equity Asia;
  • the preferred stock financing of a cybersecurity company that is developing software to protect devices in the Internet of things;
  • the acquisition by Venus Concept Ltd., a privately-held global aesthetic technology leader, of NeoGraft Solutions' hair restoration business and the concurrent equity investment in Venus Concept by certain of its existing investors;
  • the controlling investment by private equity firm LLR Partners in Eyewitness Surveillance, a leading provider of remote video monitoring solutions;
  • the Series A Preferred Stock financing of Immuta, Inc., which develops products that make data exchange easier in highly regulated industries;
  • issuance by an instrumentation and industrial technologies company of more than $2 billion of senior notes in a 144A/Regulation S private placement;
  • multiple senior notes issuances by Thermo Fisher Scientific Inc. in public offerings, with total proceeds of more than $8 billion;
  • the purchase of a company specializing in the manufacture of alignment and measurement tools by a multinational public company with a market capitalization of more than $65 billion; and
  • the sale of Barclays Bank PLC's Wealth & Investment Management Americas business to Stifel Financial  

Mr. Hultzman previously worked as a summer associate at WilmerHale, an intern at Legal Aid of North Carolina, an English as a second language instructor in Boston, Massachusetts, and a language and culture ambassador in Bonares, Spain.

Publications & News


February 21, 2017

WilmerHale Advises Immuta in $8M Series A Funding

Immuta, the unified data platform for the world's most secure organizations, announced an $8 million Series A round bringing the company's total funding to $9.5 million to date.

September 13, 2016

WilmerHale Advises Thermo Fisher Scientific in €1.6B Eurobond Public Offering

Thermo Fisher Scientific Inc. announced the completion of its public offering of €1 billion aggregate principal amount of 0.750% Senior Notes due 2024 and €600 million aggregate principal amount of 1.375% Senior Notes due 2028 at the issue prices of 99.122% of the principal amount and 99.748% of the principal amount, respectively.

December 17, 2015

Barclays Completes Sale of its US Wealth & Investment Management Business to Stifel Financial

On December 4, 2015, Barclays PLC completed the sale of its US Wealth & Investment Management Business to Stifel Financial Corp. WilmerHale represented Barclays through this transaction, which was announced on June 8, 2015.

March 27, 2015

2015 M&A Report

Our 2015 M&A Report contains a detailed review of, and outlook for, the global M&A market. Other highlights include a comparison of deal terms in public and private acquisitions, updates on takeover defenses and the current climate around proxy access, and a look at the use of social media by public companies and activist shareholders in contested situations.


Skip Navigation Links.


JD, magna cum laude, Duke University School of Law, 2014, Order of the Coif

BS, Biology, magna cum laude, Boston College, 2007

Bar Admissions

District of Columbia


North Carolina

Skip Navigation Links.